BioCentury
ARTICLE | Company News

Cephalon deal

August 8, 1994 7:00 AM UTC

CEPH (West Chester, Penn.) will co-promote Stadol NS (butorphanol tartrate) nasal spray to neurologists in the U.S. Under CEPH’s renewable, three-year deal with Bristol-Myers Squibb, the companies wil...